CWA Asset Management Group LLC purchased a new position in Agilent Technologies, Inc. (NYSE:A – Free Report) in the 3rd ...

Principal Financial Group Inc. trimmed its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 83.0% ...

Shares of Agilent Technologies Inc. A inched 0.46% higher to $134.28 Wednesday, on what proved to be an all-around great ...

Agilent Technologies Inc. announces the new Mito-rOCR Assay Kit. This easy and streamlined end-to-end solution makes sophisticated analysis of mitochondrial function available to researchers of all ...

On Monday, Agilent Technologies Inc (A) stock saw a decline, ending the day at $133.86 which represents a decrease of $-2.82 or -2.06% from the prior close of $136.68. The stock opened at $137.2 and ...

In recent trading, Agilent Technologies Inc (A) stock price has shown some volatility, fluctuating -0.14% over the last five trades and -4.25% over the past 30 trades. This represents a notable shift ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.

About Agilent Technologies and Inc. Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in ...

Telehealth company Ro has rolled out a new tool to track the supply of weight loss drugs like Ozempic and Wegovy across the U.S., as patients struggle with shortages. Novo Nordisk has been slowly ...